CD56+CD3- (absolute) cells are crucial in the immune system, primarily acting as natural killer (NK) cells. Their unique combination of CD56 positivity and CD3 negativity makes them essential for defending against pathogens and cancer cells. These cells are pivotal in diagnosing and managing immune-related conditions and cancers, highlighting their role in personalized medicine.

CD56+CD3- % is a key immunological marker identifying natural killer (NK) cells, essential in innate immunity. Elevated levels can indicate an active immune response or certain malignancies, while decreased levels may suggest impaired immunity, as seen in HIV/AIDS or post-chemotherapy. This parameter is crucial in transplant immunology for monitoring immune reconstitution and in assessing the effectiveness of immunotherapies, particularly in cancer treatments. CD56+CD3- % thus plays a significant role in diagnosing, monitoring, and treating immune and hematological disorders.

The CD57 test is offered in some clinical laboratories and is being used by some health practitioners to evaluate and follow patients diagnosed with chronic Lyme disease.

The CD57 test is offered in some clinical laboratories and is being used by some health practitioners to evaluate and follow patients diagnosed with chronic Lyme disease.

The "CD8-CD57+ Lymphocytes (Absolute)" marker on an HNK1 (CD57) panel from Labcorp represents a specific measurement of immune cells within your blood, quantified absolutely rather than as a percentage of total lymphocytes. This test focuses on a subset of natural killer (NK) cells and T lymphocytes, both critical components of your immune system's arsenal against infections and malignancies. These CD8-CD57+ cells, often referred to in the context of natural killer cell function due to their ability to directly attack and kill virus-infected cells or tumor cells without the need for prior activation, are unique. When you have a higher or lower than normal absolute count of these cells, it can be indicative of various health conditions. For example, a low absolute count of CD8-CD57+ lymphocytes is often observed in patients suffering from chronic conditions like Lyme disease, indicating a weakened immune response possibly due to the prolonged battle against the infection. On the other hand, understanding the high end of these counts is less straightforward but could suggest an active immune response to an infection or stress. This marker is particularly useful for clinicians in the context of diagnosing and managing chronic infectious diseases, as it provides insight into the state of the immune system's natural killer cell function. However, interpreting the results of this marker should always be done within the broader context of a patient's overall health, symptoms, and other laboratory findings to ensure a comprehensive understanding of their immune status.

The CD57 test is offered in some clinical laboratories and is being used by some health practitioners to evaluate and follow patients diagnosed with chronic Lyme disease.

This figure is rarely used for making treatment decisions.

CD4 and CD8 are two types of white blood cells in your blood. CD4 cells are also called T-helper cells, T-suppressor cells, and cytotoxic T-cells. They help the body fight infections. CD8 cells are also called cytotoxic T-lymphocytes. They help fight cancer and germs that live inside your cells (intracellular pathogens).

The absolute number of all CD8 cells, which include both killer and suppressor T cells. The normal range for an HIV-negative person is 150 to 1,000. It is usually higher in a person with HIV.

The Celery marker measures IgG antibodies to proteins found in celery. Results are reported as none detected, very low, low, moderate, or high. These levels reflect immune exposure and recognition rather than a true celery allergy. Interpretation should consider preparation method, portion size, and overall digestive and immune health.

CENP-A stands for centromere proteins A.

Centromere antibodies can be directed against a number of centromere proteins (CENP), including CENP-A, -B, and -C, though CENP-B is thought to be the main target.

These antibodies are found in 20% to 40% of patients with SSc and are associated with the lcSSc subtype.

Furthermore, centromere antibodies are included in the 2013 ACR-EULAR classification criteria. However, these antibodies can occur in other connective tissue diseases, including:

- systemic lupus erythematosus (SLE),

- primary biliary cholangitis,

- rheumatoid arthritis,

- and Sjögren syndrome.

CENP-B stands for centromere proteins B.

Centromere antibodies can be directed against a number of centromere proteins (CENP), including CENP-A, -B, and -C, though CENP-B is thought to be the main target.

These antibodies are found in 20% to 40% of patients with SSc and are associated with the lcSSc subtype.

Furthermore, centromere antibodies are included in the 2013 ACR-EULAR classification criteria. However, these antibodies can occur in other connective tissue diseases, including:

- systemic lupus erythematosus (SLE),

- primary biliary cholangitis,

- rheumatoid arthritis,

- and Sjögren syndrome.

Centromere B Antibody is diagnostic for the form of scleroderma known as CREST (calcinosis, Raynaud's phenomenon, esophageal immotility, sclerodactyly, and telangiectasia).

With a high specificity and a prevalence of 80 to 95%, antibodies against centromeres are pathognomonic for the limited form of progressive systemic sclerosis and can be detected even before the onset of the disease. If the corresponding clinical indication is given, the quantitative determination of antibodies with a monospecific test system, e.g. the Anti-Centromeres ELISA, is recommended.

Function:

Cerebellum is the part of the brain controlling movement and balance. Inside the cerebellar cortex there are large neurons called Purkinje’s cells. The Cerebellar antibodies test measures antibodies against the cerebellum Purkinje’s Cell Antigens.

Antibodies Appear:

- Autism

- Celiac Disease

- Gluten Ataxia

- Paraneoplastic Cerebellar Degeneration Syndrome

- Opsoclonus-Myoclonus Syndrome

Known Cross-Reactions:

gliadin, tumor cells, Milk butyrophilin

Function:

Cerebellum is the part of the brain controlling movement and balance. Inside the cerebellar cortex there are large neurons called Purkinje’s cells. The Cerebellar antibodies test measures antibodies against the cerebellum Purkinje’s Cell Antigens.

Antibodies Appear:

- Autism

- Celiac Disease

- Gluten Ataxia

- Paraneoplastic Cerebellar Degeneration Syndrome

- Opsoclonus-Myoclonus Syndrome

Known Cross-Reactions:

gliadin, tumor cells, Milk butyrophilin

Ceruloplasmin is a copper-containing enzyme that plays a role in the body's iron metabolism. This test measures the amount of ceruloplasmin in the blood.